OncBioMune Pharmaceuticals Revenue and Competitors
Estimated Revenue & Valuation
- OncBioMune Pharmaceuticals's estimated annual revenue is currently $1.1M per year.
- OncBioMune Pharmaceuticals's estimated revenue per employee is $155,000
Employee Data
- OncBioMune Pharmaceuticals has 7 Employees.
- OncBioMune Pharmaceuticals grew their employee count by 0% last year.
OncBioMune Pharmaceuticals's People
| Name | Title | Email/Phone |
|---|
OncBioMune Pharmaceuticals Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4M | 26 | 18% | N/A | N/A |
#2 | $1.4M | 9 | 0% | N/A | N/A |
#3 | $6.4M | 41 | -24% | N/A | N/A |
#4 | $2.5M | 16 | -6% | N/A | N/A |
#5 | $3.3M | 21 | 40% | N/A | N/A |
#6 | $2.5M | 16 | -6% | N/A | N/A |
#7 | $0.8M | 5 | 0% | N/A | N/A |
#8 | $0.9M | 6 | -14% | N/A | N/A |
#9 | $6.4M | 41 | 8% | N/A | N/A |
#10 | $0.3M | 4 | 100% | N/A | N/A |
What Is OncBioMune Pharmaceuticals?
OncBioMune Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary Vaccine Technology that is designed to stimulate the immune system to attack its own cancer while not hurting the patient. Our lead product, ProscaVax(r) is scheduled to commence a Phase 2 clinical study in early 2016. OncBioMune also has a portfolio of targeted therapies, some of which are biosimilars to blockbuster drugs. OncBioMune is headquartered in Baton Rouge, LA.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Baton Rouge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 7 | 17% | N/A |
#2 | $0.5M | 7 | -22% | N/A |
#3 | $0.5M | 7 | 0% | N/A |
#4 | $0.5M | 7 | 0% | N/A |
#5 | $0.5M | 7 | -12% | N/A |